IRIS
BOCCUTO, ADELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.375
NA - Nord America 2.220
AS - Asia 817
SA - Sud America 183
AF - Africa 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.191
RU - Federazione Russa 612
GB - Regno Unito 465
IT - Italia 406
IE - Irlanda 306
SG - Singapore 271
CN - Cina 227
BR - Brasile 165
SE - Svezia 153
DE - Germania 129
HK - Hong Kong 108
FR - Francia 103
IN - India 57
FI - Finlandia 47
UA - Ucraina 47
VN - Vietnam 39
ES - Italia 31
KR - Corea 28
JP - Giappone 19
BE - Belgio 16
TR - Turchia 16
CA - Canada 13
NL - Olanda 11
PL - Polonia 11
BD - Bangladesh 10
MX - Messico 10
IR - Iran 9
AR - Argentina 8
AT - Austria 7
CZ - Repubblica Ceca 6
GR - Grecia 6
IQ - Iraq 5
EC - Ecuador 4
ID - Indonesia 4
MA - Marocco 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
JM - Giamaica 2
LT - Lituania 2
LU - Lussemburgo 2
OM - Oman 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
TN - Tunisia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.611
Salva come PNG Salva come JPEG
Città #
Southend 410
Dublin 303
Dallas 298
Fairfield 221
Chandler 198
Moscow 179
Singapore 153
Ashburn 146
Santa Clara 140
Siena 111
Hong Kong 102
Beijing 96
Seattle 83
Woodbridge 80
Houston 73
Ann Arbor 71
Cambridge 71
Wilmington 61
Princeton 54
Munich 52
New York 51
Jacksonville 39
Milan 37
Los Angeles 35
Rome 30
Helsinki 26
Seoul 25
Hefei 24
Málaga 22
Bengaluru 21
Boardman 21
São Paulo 19
Portsmouth 17
Brussels 16
San Mateo 16
Lauterbourg 15
San Diego 15
Tokyo 15
Ho Chi Minh City 14
Redondo Beach 13
Buffalo 12
Dearborn 12
The Dalles 12
Shanghai 11
Düsseldorf 10
Florence 10
London 10
Redwood City 10
Brescia 9
Council Bluffs 9
Frankfurt am Main 9
Fremont 9
Lappeenranta 9
Nuremberg 9
Turku 9
Nanjing 8
Atlanta 7
Brooklyn 7
Dong Ket 7
Izmir 7
Rio de Janeiro 7
Roccagorga 7
Warsaw 7
Hanoi 6
Indianapolis 6
Mexico City 6
Mumbai 6
Naples 6
Phoenix 6
Toronto 6
Vienna 6
Andover 5
Belo Horizonte 5
Brasília 5
Denver 5
North Bergen 5
Paris 5
Perugia 5
Zanjan 5
Amsterdam 4
Bangalore 4
Cagliari 4
Changsha 4
Chennai 4
Lancaster 4
Lograto 4
Manchester 4
Montreal 4
Orem 4
Saint-Fons 4
Stockholm 4
Abidjan 3
Ankara 3
Brno 3
Buenos Aires 3
Chicago 3
Como 3
Draper 3
Empoli 3
Guangzhou 3
Totale 3.743
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 299
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 277
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 277
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 264
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 257
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 236
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 234
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 228
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 225
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 218
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 217
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 216
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 199
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 186
Novel antiviral strategies against emerging viral diseases 180
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 178
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 157
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 157
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 155
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 153
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 133
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 126
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 120
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 119
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 119
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 119
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 115
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis 107
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 105
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 102
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 95
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 94
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 40
null 32
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 9
Totale 5.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021363 0 0 0 0 0 64 65 60 58 58 22 36
2021/2022702 26 86 57 88 43 46 43 47 34 57 61 114
2022/2023613 41 98 71 60 46 103 32 38 49 34 25 16
2023/2024521 18 17 48 31 5 147 168 10 0 15 12 50
2024/20251.087 28 40 157 51 110 77 41 90 113 69 110 201
2025/20261.601 150 293 249 348 547 14 0 0 0 0 0 0
Totale 5.748